Moderna’s Covid vaccine for children has been given full FDA approval, making it the first such shot for kids in the U.S. that will no longer be administered under an emergency use authorization.

The U.S. Food and Drug Administration approved "Spikevax," Moderna's vaccine for children aged 6 months to 11 years old. The vaccine was previously only available to children through emergency use authorization after approval in Jan. 2022. Approval was expanded to people 12 years and older last year.